CDC Anthrax Scare Blamed on Breach of Protocol

Posted on by admin

CDC is blaming its anthrax mishap on a breach of protocol. The breach may have exposed 84 CDC workers to live anthrax bacteria.



Read more on sciencespacerobots.com



SOURCE: Health News from ScienceSpaceRobots.com – Read entire story here.

Related posts:

  1. Study Tracks Patients After Prolonged Mechanical Ventilation SOURCE: Kaiser Health News – Read entire story here. ...
  2. DSMA January — Looking Forward Like many of you, Allison and I have been spending time reflecting on the past year, and thinking about where this new year might take us. Turns out, this month's Diabetes Social Media Advocacy DSMA Blog Carnival asked just that question:What is t... ...
  3. Diabetesaliciousness © 2007 – 2024: I’m Attending #ada2024 Thanks To The Amazing #dedoc° / #dedocvoices Getting my D advocacy on! Hey diabetes peeps and the likes there of – Wanted to […] ...
  4. Scientists Create Partly Human Yeast Scientists have created thriving strains of partly human yeast. Read more on sciencespacerobots.com ...
  5. Judge Considers House GOP’s Case Against Obama’s Health Law – Wall Street Journal U.S. News & World ReportJudge Considers House GOP's Case Against Obama's Health LawWall Street JournalHouse Republicans filed a lawsuit in November claiming administration officials overstepped their authority by paying back insurers for discounts on health-plan deductibles they are required to offer low-income enrollees. The lawmakers allege that ...Administration asks judge to toss House health care suitU.S. News & World ReportHouse, Obama Administration Clash Over Health Care LawThe National Law Journal (registration)First hearing in House lawsuit over Obama health lawMedical Xpressall 221 news articles » ...

Related Posts

Lung cancer treatment hope raised

A new type of treatment could double the chances of survival for some patients suffering from the most common type of lung cancer, according to scientists. Drug company Roche has been carrying out tests on an immunotherapy treatment, with early results suggesting it could be a better option than chemotherapy for those with non-small cell lung cancer.